This useful interaction in between the serotoninergic and central dopaminergic methods continues to be shown in experiments with haloperidol, a D2 receptor antagonist that attenuates the psychotomimetic outcomes of psilocybin [5].This accomplishment will likely allow for the broad-scale production of Normally happening psilocybin and standardizatio